(Q53094807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Nicolas Calo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Jean-François Dufour

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

11

Bostjan Humar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Pierluigi Ramadori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Cyril Sobolewski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Yannick Romero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Christine Maeder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Margot Fournier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Fu-Ping Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Matti Poutanen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Serge Nef

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Michelangelo Foti

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

language of work or name

English

0 references

publication date

24 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

1871-1881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Current concepts and management approaches in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

New aspects of the Warburg effect in cancer cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Non-glucose metabolism in cancer cells--is it all in the fat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNAs in metabolism and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNAs in insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Post-transcriptional stimulation of gene expression by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

microRNAs and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Dual role of microRNAs in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNAs in hepatic pathophysiology in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNAs and liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Regulation of hepatocarcinogenesis by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-21: a novel therapeutic target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Role of miR-21 in the pathogenesis of atrial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

21 January 2018

MicroRNAs and fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

miRNA*: a passenger stranded in RNA-induced silencing complex?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

The magic and mystery of miR-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Long-term persistence of functional thymic epithelial progenitor cells in vivo under conditions of low FOXN1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: a role for IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

miRWalk2.0: a comprehensive atlas of microRNA-target interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

PPARα is regulated by miR-21 and miR-27b in human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

The involvement of microRNAs in Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Diabetes mellitus, a microRNA-related disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNAs in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNAs in fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Expression and localization of microRNAs in perinatal rat pancreas: role of miR-21 in regulation of cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

Role of microRNA-21 in regulating 3T3-L1 adipocyte differentiation and adiponectin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-310822

10.1136/GUTJNL-2015-310822

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27222533%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference